Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation-Reference-Cited by-同舟云学术

Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation

Published:2023-08 Issue: Volume: Page:
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Yegya-Raman Nikhil,Friedes Cole,Lee Sang Ho,Iocolano Michelle,Duan Lian,Wang Xingmei,Li Bolin,Aggarwal Charu,Cohen Roger B.,Su William,Doucette Abigail,Levin William P.,Cengel Keith A.,DiBardino David,Teo Boon-Keng Kevin,O'Reilly Shannon E.,Sun Lova,Bradley Jeffrey D.,Xiao Ying,Langer Corey J.,Feigenberg Steven J.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference21 articles.

1. Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer;Antonia;New Engl J Med,2017

2. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC;Antonia;New Engl J Med,2018

3. Predictors of pneumonitis after conventionally fractionated radiotherapy for locally advanced lung cancer;McFarlane;Int J Radiat Oncol Biol Phys,2021

4. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis;Palma;Int J Radiat Oncol Biol Phys,2013

5. PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy (CRT) in patients with stage III, locally advanced, unresectable NSCLC;Paz-Ares;Ann Oncol,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifying Regional Radiation-Induced Lung Injury in Patients Using Hyperpolarized 129Xe Gas Exchange Magnetic Resonance Imaging;International Journal of Radiation Oncology*Biology*Physics;2024-09

2. Patterns and Incidence of Pneumonitis and Initial Treatment Outcomes with Durvalumab Consolidation Therapy after Radical Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer;Cancers;2024-03-15

3. Decreased risk of radiation pneumonitis with concurrent use of renin-angiotensin system inhibitors in thoracic radiation therapy of lung cancer;Frontiers in Medicine;2023-10-12

4. Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2023-10